Variants in the neuronal sodium channel gene SCN8A have been implicated in several neurological disorders. Early infantile epileptic encephalopathy type 13 results from de novo gain-of-function mutations that alter the biophysical properties of the channel. Complete loss-of-function vari-
ants of SCN8A have been identified in cases of isolated intellectual disability. We now report a novel heterozygous SCN8A variant, p.Pro1719Arg, in a small pedigree with five family members affected with autosomal dominant upper limb isolated myoclonus without seizures or cognitive impairment. Functional analysis of the p.Pro1719Arg variant in transfected neuron-derived cells demonstrated greatly reduced Na v 1.6 channel activity without altered gating properties. Hypomorphic alleles of Scn8a in the mouse are known to result in similar movement disorders. This study expands the phenotypic and functional spectrum of SCN8A variants to include inherited nonepileptic isolated myoclonus. SCN8A can be considered as a candidate gene for isolated movement disorders without seizures.
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The SCN8A gene (MIM# 600702) encodes the neuronal voltage-gated sodium channel Na v 1.6, which is localized at the axon initial segment and functions in initiation and propagation of action potentials. Na v 1.6 is also concentrated at nodes of Ranvier in myelinated neurons, including sciatic nerve, and is expressed at a high level in cerebellar Purkinje cells. During the past 5 years, SCN8A has been found to have a major role in sporadic epilepsy. De novo missense mutations of SCN8A have
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. (Wagnon & Meisler, 2015) . Functional analysis has demonstrated that the most common mechanism is gain-of-function alterations in biophysical properties of Na v 1.6 that result in neuronal hyperexcitability (Anand et al., 2016; Butler et al., 2017; Gardella et al., 2016; Han, Jang, Lee, Shin, & Park, 2017) . Heterozygous loss-of-function mutations of SCN8A have been associated with isolated cognitive impairment in two individuals with de novo mutations (Wagnon et al., 2017) and one family with the protein truncation variant p.Pro1719Argfs*6 (MIM# 614306). In the mouse, homozygosity for partial loss-of-function alleles of Scn8a results in movement disorders including ataxia, tremor, and dystonia, whereas homozygosity for null alleles results in paralysis and juvenile lethality (Kearney et al., 2002; O'Brien & Meisler, 2013) .
We now describe a missense variant of SCN8A in a family with nonepileptic essential myoclonus. The proband is a 35-year-old female with onset of isolated myoclonus at age 5 ( Figure 1A , II-2). In order to identify the genetic basis for the disorder, we performed whole-exome sequencing (WES) in individuals II-2 and III-2. The study was approved by the University College London ethics committee (UCLH project 06/N076), and written informed consent was obtained from all participating subjects. DNA was extracted from peripheral lymphocytes following a standard protocol. Point mutations and copynumber variants in SGCE, the most common genetic cause of autosomal dominant myoclonus-dystonia (MIM# 159900), were previously excluded (Carecchio et al., 2013) .
WES was carried out at the Institute of Neurology, University College London, using Illumina, (Santa Clara, CA, USA) Nextera Rapid Capture according to the manufacturer's recommendations. Indexed and pooled libraries were sequenced on Illumina's HiSeq3000. Bioinformatic analysis was performed as previously described (Mencacci et al., 2015 (Kircher et al., 2014) .
After filtering, 11 variants remained (Supplemental Table 2 ). Among these, SCN8A is the only gene with previous association with movement disorders and a high intolerance score for missense and lossof-function variants (z = 7.7 and pLI = 1.0) (exac.broadinstitute.org). To determine experimentally whether P1719R is a deleterious variant, we carried out functional comparison of mutant and wildtype Na v 1.6. The substitution P1719R was introduced into the tetrodotoxin (TTX)-resistant derivative of the full-length Na v 1.6 cDNA clone, as previously described (Wagnon et al., 2016) . Site-directed mutagenesis was carried out with the QuikChange II XL kit (Agilent Technologies, Santa Clara, CA, USA). The 6-kb open reading frame was re-sequenced to confirm the absence of other mutations.
Channel activity was characterized in DRG-neuron derived ND7/23 cells (Sigma-Aldrich, St. Louis, MO, USA). Cells were cultured and transfected as previously described (Wagnon et al., 2016) . Forty-eight hours after transfection with 5 g of Na v 1.6 alpha subunit cDNA and 0.5 g of the fluorescent m-Venus bioreporter, electrophysiological recordings of fluorescent cells were made. Recording was carried out in the presence of 500 nM TTX to block endogenous sodium currents. Currents were recorded using the whole-cell configuration of the patch clamp recording technique as previously described (Wagnon et al., 2016) .
Cells expressing the Na v 1.6-P1719R variant demonstrated inward sodium current that was significantly reduced compared with cells expressing wild-type channels: −27.3 ± 5.3 pA/pF (n = 9) for mutant channel compared with −108 ± 21 pA/pF (n = 9) for wild-type channel (P < 0.01) (Figure 2A and B) . The voltage dependence of mutant channel activation and inactivation did not differ from wildtype ( Figure 2C-F) . The finding of partially reduced channel activity for P1719R is novel, since previously characterized deleterious variants resulted either in shifted voltage dependence of activation (Estacion et al., 2014) , delayed channel inactivation (Wagnon et al., 2016) , or complete loss of channel activity (Wagnon et al., 2017) .
Individuals with epileptic encephalopathy due to gain-of-function mutations of SCN8A often exhibit movement disorders and other neurological signs such as hypotonia, ataxia, dystonia, hyperreflexia, and choreoathetosis . Severe hypotonia in these individuals is responsible for loss of intentional movement in 50% of cases . SCN8A variants have not been previously reported in individuals with isolated movement disorders. This absence may reflect the lack of sequencing data in this population or the failure to recognize the relevance of missense variants. The identification of SCN8A-P1719R cosegregating with isolated nonepileptic myoclonus demonstrates that mutation of SCN8A can result in isolated movement disorders in patients.
Variants of SCN8A with gain-of-function and elevated channel activity, either due to premature channel opening or delayed channel closing, result in epileptic encephalopathy . At the other extreme, heterozygosity for complete loss-of-function alleles of SCN8A can result in isolated intellectual disability (Trudeau, Dalton, Day, Ranum, & Meisler, 2006; Wagnon et al., 2017) . In rare cases, seizures have been seen in individuals with loss-of-function alleles of SCN8A lacking residual activity (Blanchard et al., 2015; Moller et al., 2016) . Partial loss-of-function with residual activity, as demonstrated here for P1719R, has not previously been described for a pathogenic variant of human SCN8A. The dominant phenotype of this pore loop mutation could result from impaired trafficking of the coexpressed wild-type Na v 1.6, possible because of the recently described dimerization of the subunit (Clatot et al, 2017) .
As another possibility, this mutation could impair glycosylation or trafficking of the channel protein (e.g., Jones et al., 2016) . The data presented here demonstrate that heterozygosity for partial loss-offunction of SCN8A can be associated with movement disorders without seizures.
In the mouse, homozygosity for the hypomorphic Scn8a medJ allele, a splice site variant with 90% reduction in Nav1.6 protein, results in severe progressive dystonia (Sprunger, Escayg, Tallaksen-Greene, Albin, & Meisler, 1999) . A second hypomorphic allele, Scn8a 9J , results in early onset tremor and adult onset dystonia (Jones et al., 2016) .
Complete loss of mouse Scn8a associated with homozygosity for a null allele results in hind limb paralysis and death (Burgess et al., 1995) . Conditional inactivation of Scn8a restricted to cerebellar Purkinje and granule layer neurons also leads to pronounced ataxia (Levin et al., 2006) , and dysfunction of cerebellar neurons could contribute to myoclonus in the family described here. Cerebellar dysfunction has been implicated in the pathogenesis of other forms of nonepileptic myoclonus such as SGCE-related myoclonus-dystonia (Carbon et al., 2013; Hubsch et al., 2011) . Furthermore, we observed improvement of myoclonus with alcohol intake in the adult subject with SCN8A-P1719R, an effect likely to occur through modulation of the activity of cerebellar neurons.
Three affected family members were demonstrated to carry the 
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